General MedicationsORALGeneric
RITONAVIR
RITONAVIR
Standard Dose
100MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview RITONAVIR is listed in Drugs@FDA under application 205801 (ANDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient RITONAVIR Form and strength CAPSULE;ORAL - 100MG Sponsor HIKMA Submission history Latest submission status date: 2020-12-03 00:00:00.
Structured Monograph
Clinical summary
Approval overview RITONAVIR is listed in Drugs@FDA under application 205801 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient RITONAVIR Form and strength CAPSULE;ORAL - 100MG Sponsor HIKMA Submission history Latest submission status date: 2020-12-03 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.